A Systematic Review and Network Meta-Analysis to Assess the Relative Efficacy of Antipsychotics for the Treatment of Positive and Negative Symptoms in Early-Onset Schizophrenia

@article{Harvey2016ASR,
  title={A Systematic Review and Network Meta-Analysis to Assess the Relative Efficacy of Antipsychotics for the Treatment of Positive and Negative Symptoms in Early-Onset Schizophrenia},
  author={R. Harvey and A. James and G. Shields},
  journal={CNS Drugs},
  year={2016},
  volume={30},
  pages={27-39}
}
IntroductionEarly-onset schizophrenia (EOS) is a serious debilitating disorder with considerable morbidity and a reduced life expectancy; therefore, early diagnosis and effective treatments are particularly important. Negative symptoms are more prominent in adolescents and children (compared with adults), and are key predictors of worse functional and clinical outcomes in EOS. Therefore, this study aimed to explore the relative efficacy of antipsychotics used in the treatment of EOS, with a… Expand
41 Citations
Acute Antipsychotic Treatment of Children and Adolescents With Schizophrenia-Spectrum Disorders: A Systematic Review and Network Meta-Analysis.
  • 38
Treating Negative Symptoms in Schizophrenia: an Update
  • 89
  • PDF
Meta-Review: Network Meta-Analyses in Child and Adolescent Psychiatry.
  • 3
Olanzapine Versus Risperidone in Children and Adolescents with Psychosis: A Meta-Analysis of Randomized Controlled Trials
  • 6
  • PDF
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 51 REFERENCES
Treatment of early-onset schizophrenia
  • 37
Atypical antipsychotics for psychosis in adolescents.
  • 26
A trial of quetiapine compared with risperidone in the treatment of first onset psychosis among 15- to 18-year-old adolescents
  • 44
  • Highly Influential
Practice parameter for the assessment and treatment of children and adolescents with schizophrenia.
  • J. McClellan, S. Stock
  • Psychology, Medicine
  • Journal of the American Academy of Child and Adolescent Psychiatry
  • 2013
  • 174
  • PDF
A multiple-center, randomized, double-blind, placebo-controlled study of oral aripiprazole for treatment of adolescents with schizophrenia.
  • 216
  • Highly Influential
...
1
2
3
4
5
...